Clinical trial
The Comparative Effectiveness of Warfarin and New Oral Anticoagulants for the Extended Treatment of Venous Thromboembolism
NCT03292666 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Comparative Effectiveness of Warfarin and New Oral Anticoagulants for the Extended Treatment of Venous Thromboembolism
- Lead sponsor
- University of California, San Francisco
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2010
- Completion date
- June 21, 2022
- Enrollment
- 39,603 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
anticoagulants and bleeding disorders, venous thromboembolism